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Abstract
Background: To estimate the cost and cost-effectiveness of a project administering de-worming and weekly iron-folic acid
supplementation to control anaemia in women of reproductive age in Yen Bai province, Vietnam.
Methods and Findings: Cost effectiveness was evaluated using data on programmatic costs based on two surveys in 2006 and
2009 and impact on anaemia and iron status collected in 2006, 2007, and 2008. Data on initial costs for training and educational
materials were obtained from the records of the National Institute of Malariology, Parasitology and Entomology and the Yen Bai
Malaria Control Program. Structured questionnaires for health workers at district, commune and village level were used to collect
ongoing distribution and monitoring costs, and for participants to collect transport and loss of earnings costs. The cost per
woman treated (defined as consuming at least 75% of the recommended intake) was USD0.76 per annum. This estimate includes
financial costs (for supplies, training), and costs of health care workers’ time. Prevalence of anaemia fell from 38% at baseline, to
20% after 12 months. Thus, the cost-effectiveness of the project is assessed at USD 4.24 per anaemia case prevented per year.
Based on estimated productivity gains for adult women, the benefit:cost ratio is 6.7:1. Cost of the supplements and
anthelminthics was 47% of the total, while costs of training, monitoring, and health workers’ time accounted for 53%.
Conclusion: The study shows that weekly iron-folic acid supplementation and regular de-worming is a low-cost and cost-
effective intervention and would be appropriate for population-based introduction in settings with a high prevalence of
anaemia and iron deficiency and low malaria infection rates.
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Introduction
WHO estimates suggest that globally up to 500 million women
of reproductive age suffer from anaemia. Women and children are
most vulnerable due to greater iron requirements and those in
resource constrained countries are particularly at risk [1]. Severe
maternal anaemia increases the risk of maternal and neonatal
mortality and morbidity while less severe anaemia and iron
deficiency have been linked to sub-optimal fetal growth,
premature birth and low birth weight, as well as iron deficiency
in infants [2–4] which may impair cognitive development [5]. On
a broader scale the reduced capacity for work and education due
to anaemia and iron deficiency can adversely impact a
population’s social and economic development [6].
WHO guidelines recommend daily iron supplementation for
pregnant women and children 6–24 months where anaemia rates
are 40% or more [7]. A recent international expert consultation
organized by WHO went further and recommended weekly
supplementation with iron and folic acid for all non-pregnant
women of reproductive age in areas where anaemia prevalence is
greater than 20% [8]. A systematic review of 25 original studies
concluded that this approach of weekly iron and folic acid
supplementation was safe and also effective in improving
haemoglobin concentration in women of reproductive age [9].
However, there is no data on cost and cost-effectiveness of
population-based weekly supplementation programs, and limited
data on other nutritional supplementation programs.
In Vietnam, there has been an increasing awareness of
nutritional deficiencies and anaemia, particularly in rural
populations. A national survey in 2000 found anaemia rates were
24.3% for non-pregnant women nationally (26.3% in rural areas),
and 32.2% in pregnant women (33.8% in rural areas) [10].
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with low income, compounded by high rates of infection with soil-
transmitted helminths, particularly hookworm. A study of
pregnant women in the rural central highlands in 2001 identified
anaemia prevalence in pregnant women, post-partum women and
non-pregnant women of 53%, 62% and 54% respectively [11].
As a consequence the Vietnam National Nutrition Strategy
2011–2020 has the reduction of iron deficiency anemia in children
less than 5 years of age and reproductive-age women as an
objective. However the costs of potential strategies for achieving
this are currently unknown.
In 2006, following a baseline study of the prevalence of
anaemia, iron deficiency and soil transmitted helminth infection
prevalences [12], we introduced an anaemia and helminth control
program consisting of weekly iron-folic acid supplementation and
regular deworming for women of reproductive age in Yen Bai, a
rural province in the northern mountainous region of Vietnam.
Surveys were conducted to assess program impact, compliance
and cost [13,14]. We report here the cost and cost-effectiveness of
the de-worming and weekly iron-folic acid intervention, which has
now been delivered to women in Yen Bai province since May
2006.
Materials and Methods
Program implementation, compliance and impact
assessment
In May 2006 the National Institute of Malariology, Parasitology
and Entomology (NIMPE) and partners introduced a pilot
program consisting of weekly iron-folic acid supplementation
and periodic de-worming for women of reproductive age in Yen
Bai province. Yen Bai is a mountainous, predominantly rural
province located approximately 180 km from Hanoi. The
intervention was implemented in two districts targeting all
50,000 women of reproductive age, and a cost analysis was
undertaken.
The integration of the weekly iron-folic acid supplement and
deworming program into the existing health infrastructure in Yen
Bai province has been described elsewhere [14]. In brief,
community leaders and health staff at all levels were sensitized,
promotional materials were developed, and village health workers
were trained to distribute supplements each month to non-
pregnant women. Pregnant women were advised to use the daily
supplements provided through Government antenatal clinics, or if
these were not available, to use a double dose of the weekly
supplements. Non-pregnant women were given supervised doses of
albendazole (400 mg) every four months in the first year of the
program and every six months thereafter.
The impact of the program on women’s iron and helminth
infection status in the first 12 months was assessed using structured
questionnaires, stool examination and haemoglobin assessment at
the field site, and blood sample analysis for ferritin, soluble
Transferrin Receptor and C-Reactive Protein (to identify the
presence of acute infection). These surveys were conducted at 3
and 12 months post-implementation [15].
With evidence of the program’s positive impact on women’s
iron status the weekly supplement program with twice-yearly de-
worming was scaled up to province level (with an estimated target
group of 250,000 women of reproductive age) commencing March
2008. A follow-up survey was repeated at 30 months post-
implementation.
The effectiveness of the distribution system and women’s
compliance were assessed by an independent Non-Government
Organization at 10 weeks and 18 and 36 months post-
implementation. Structured questionnaires were administered to
assess the availability of supplements at each level of the
distribution chain and women’s attitude about, and their history
of, taking the supplements [13].
Program cost assessment
Costs of the intervention included both programmatic costs and
health system costs. These costs were identified through the
accounts of the relevant agencies and structured interviews with
health staff at each level of the distribution chain. In addition,
participating women were surveyed to assess their estimate of costs
involved in accessing the supplements. Health staff interviews and
participating women surveys were conducted in 2006 and 2009.
Programmatic costs included cost of supplements, which were
originally distributed in tamper-proof bottles (UNICEF, Copenha-
gen), and after 12 months sourced domestically in blister packs
consisting of 6 tear-off strips of 5 tablets, each strip enough for one
month (Nam Ha Pharmaceutical Company, Nam Dinh, Viet-
nam). The albendazole for helminth control was kindly donated by
WHO. In 2006 Albendazole sourced from UNICEF was quoted at
USD1.617/100 tabs. Distribution/storage costs were for receiving the
supplements at NIMPE and then periodically transporting them to
Yen Bai city. After 12 months the cost of delivery to the province
was included in the contract with the manufacturer. Once there,
existing distribution channels of the public health care system were
utilized. Promotional and educational material costs included the
development and production of posters and flip-charts, which
were then disseminated via the public health system. Training of
trainers involved national staff training staff from the provincial
level, who then trained district, commune and village level health
workers. Monitoring involved printing forms, distributing them to
the relevant level (village level for iron supplements: commune
level for de-worming), and then returning them to Yen Bai and
monthly mailing back to NIMPE. All these costs could be
identified from financial records. Amortization of training and
promotional material production costs was assumed to be over 5
years. The discount rate assumed was zero: using a higher discount
rate would increase costs by a trivial amount.
Health system costs included institutional administrative costs
and health worker income. Personnel costs were imputed based on
information obtained from interviews with district, commune and
village health workers about their total salary and the proportion
of time they spent on this intervention. No monetary value was
assigned to the women’s time since the time required per person
was very modest and respondents stated that this did not involve
loss of work time or incur a financial cost.
Costs resulting from the research activities on program impact
and compliance rates are not included. All cost data were collected
in Viet Nam dong and converted to US dollars using the exchange
rate on March 10 2010 (USD1.00= VND18,685).
Benefit-Cost Analysis
Effectiveness data were obtained from the two pilot districts,
which were surveyed at baseline and at 3, 12 and 30 months post-
implementation for the impact on anaemia and helminth infection
status, and independent compliance monitoring at 10 weeks, 18
and 36 months post-implementation. The treatment cost per
woman was calculated based on total cost divided by the number
of women taking 75% or more of the supplements. The cost per
anaemia case prevented was calculated as the total cost of the
program (both set up and maintenance costs) divided by the
difference between the total number of anaemia cases at baseline
and the number of anaemia cases after 12 months of implemen-
tation. The benefit:cost ratio was estimated using the methods
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labour market productivity for women of reproductive age after
removal from anaemia.
Results
The basis and source of data for programmatic and health
system costs are shown in Table 1. Promotional and training costs
are amortized over 5 years as a realistic assumption of the lifespan
of printed materials and accounting for staff turnover in the health
care system.
A breakdown of unit costs is shown in Table 2. The total annual
cost of the program was USD 133,900 of which programmatic
costs made up 69% of the total, the major component being the
supply and transport of supplements (47% of the total). Health
care system costs made up 31% of the total, the largest component
of which was support for nearly 2000 village health workers.
The effective target group accessed was calculated at 70% of the
250,00 eligible women or 175,581 women of reproductive age.
This was based on the independent monitoring survey one year
after the province-wide expansion of the program, at which time
81% of surveyed women were receiving the supplements regularly
and 87% of those were taking 75% or more of the supplied
supplements [13].
As a result the calculated cost per woman treated is USD 0.76
per year (USD133900 / 175581).
The long-term impact of the Yen Bai program is shown in
Table 3. After 12 months of the project mean hemoglobin
increased from 122 g/L to 130g/L, the prevalence of anaemia
decreased from 38% to 20% and the prevalence of hookworm
infection decreased from 76% to 22% [13]. Assuming that
anaemia cases prevented is the measure of effectiveness, the cost-
effectiveness of the intervention is USD 4.24 per anaemia case
prevented (USD133900 / (175581618)). Rates of severe anemia in
women of reproductive age fell from 1.1% to 0% after 3 months of
the intervention [15]. We used calculations from Horton and Ross
(2003) [6] to estimate a benefit:cost ratio based on improved
labour market productivity for women of reproductive age. These
authors estimate that the productivity gains for an individual
removed from anaemia are 5% in manual occupations (70% of
employment in a country such as Viet Nam), and 17% in heavy
manual occupations (which form 12.7% of employment in manual
occupations in Viet Nam: the share of agriculture in GDP is
22.1%) [16]. There are an estimated 22.2 m women of
reproductive age (15–44) in Viet Nam out of a working-age
population (15–64) of 60.6 m (and total population 89 m) [17].
Reducing anaemia rates by 18.2% for women of reproductive age
therefore constitutes a 6.7% reduction in anaemia on average in
the labour force (using the proportion of women of reproductive
age in the overall labour force in Vietnam: women’s labour force
participation rate is similar to men’s). The estimated dollar value
per capita of the productivity gains are calculated as USD1.29, i.e.
$5.18 per woman of reproductive age, as compared to the cost of
supplementation per woman of reproductive age of USD0.76.
Hence the benefit: cost ratio is approximately 6.7:1, just based on
improvements in productivity of women of reproductive age in the
workforce. This means that for each dollar invested in a weekly
iron supplementation and de-worming program the monetary
value in terms of productivity was USD6.70. There may be
additional financial benefits associated with reductions in other
health care costs such as those associated with reduced maternal
and infant mortality, and a reduction in neural tube defects which
cannot readily be quantified. In addition there are possible effects
on reduced anaemia in children and men associated with de-
worming women of reproductive age and a consequent reduction
in helminth transmission.
Discussion
The provision of iron-folic acid supplements on a weekly basis
for women of reproductive age is aimed at improving iron stores,
particularly prior to pregnancy and during the first trimester
before women access ante-natal care. Pre-pregnancy weekly
supplements that contain folic acid may also decrease the risk of
neural tube defects. A successful supplementation program must
include training of health care system workers, provision of
accessible educational materials for the target group and the
broader community and a reliable distribution system. Therefore
these costs need to be incorporated into the overall cost of an
intervention program.
We have demonstrated the effective uptake of weekly iron-folic
acid supplementation by 70% of woman in Yen Bai province with
an annual cost of USD 0.76/woman. This compares to estimates
by the National Institute of Nutrition that only 20% of pregnant
women are covered by the national antenatal program of daily
iron supplementation for which there is no costing. [18]. The
Table 1. Basis for costs and source of data.
Project costs
Iron-folic acid
supplements
Promotion
Training
Monitoring
USD4.55/9000 tablets: 52 tablets/year, target population 250,000; costs, insurance, freight included. Source Project
documentation, University of Melbourne/NIMPE. Distribution and storage USD3,597: source Yen Bai People’s
Committee financial records
Promotional material development and production: amortized over 5 years. Source Project documentation, University
of Melbourne
Training of trainers amortized over 5 years: USD85.67/year; training of local health staff USD10/person, 2000 staff,
amortized over 5 years. Source Project documentation, University of Melbourne/NIMPE. Support provided by NIMPE:
source NIMPE financial records
Health care system costs
National Institute
District Health Service
Commune Health Service
Village Health Workers
Source: NIMPE financial records
Average DHW income (USD260/month) X share of monthly hours worked on project (11%) X 3 workers/district X 7
districts
Average CHW income (USD157/month) X share of monthly hours worked on project (10%) X 175 communes
Average VHW income (USD13/month) X share of monthly hours worked on project (30%) X 2000 individuals
Non-salary costs are also incurred at each level (obtained from worker surveys)
CHW = commune health worker, DHW = district health worker, VHW = village health worker.
doi:10.1371/journal.pone.0023723.t001
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staff training, production and distribution of educational materials
and regular monitoring.
The possible reasons for the higher uptake of the weekly
s u p p l e m e n t sa r em a n y .O n el i k e l yr e a s o nf o rt h ed i f f e r e n c ei s
convenience. Antenatal supplements for pregnant women have to be
accessed at the Commune Health Station, which is generally further
for women to travel. Weekly supplements for women of reproductive
age in the program reported here are accessed at village level. The
2009 survey identified that ittook women an average of 17 minutes to
access the distribution point for weekly supplements.
Another reason for high compliance with the weekly program
was the maintenance of a reliable supply. A previous study has
shown that a poor distribution system and irregular availability
were the most significant environmental risk factors for taking iron
supplementation continuously [19]. Also, weekly supplements may
be better tolerated, with less frequent side-effects thereby
increasing acceptance and compliance. The extensive training
and community education program was another positive factor
which increased acceptance of the supplements as a valuable
contribution to women’s health.
The main limitation of the impact evaluation was the lack of a
control arm where no intervention was given. However, we
considered it unethical to withhold iron-folic acid supplementation
and deworming from women of reproductive age over a long
period of time given the evidence from short-term studies on the
efficacy of weekly iron-folic acid supplementation [8].
A previous study in Viet Nam followed women of reproductive
age receiving weekly supplements, some of whom became
pregnant at various points during the 12 months of follow-up.
Those who had a longer period of weekly supplementation prior to
pregnancy maintained higher Hb concentration during pregnancy
[20]. Our study did not have a sample group large or accessible
enough to allow an assessment of long-term pregnancy outcomes.
With a larger sample, it would be possible to extend our
calculations to estimate the cost per death averted with a reduction
of the prevalence of severe anemia in pregnant women. The
relative risk of mortality associated with a 10 g/L increase in
hemoglobin is estimated as 0.75 for maternal mortality, and 0.72
for perinatal mortality [21].
The annual cost of USD0.76 per woman treated is consistent
with a cost estimate of USD10-13 per pregnancy [22,23], since
pregnant women receive more tablets. A recent trial in northern
China identified an annual cost of USD40.00 to improve
antenatal, delivery and postnatal care of which 22% (USD8.80)
was to supply and distribute daily supplements to pregnant women
[24]. Data on cost per pregnancy of daily iron supplementation is
quite weak. Baltussen et al (2004) [22] use the WHO ‘‘ingredients’’
approach to estimate costs (at 95% coverage) for various regions.
For those countries in the Southeast Asia region (SearD) with high
adult and child mortality rates, they estimate the cost as $10.12
(but as high as $46.04 per pregnancy in the low mortality countries
in the Europe region, EurA). Behrman, Alderman and Hoddinott,
2004 [23], cite estimates for Nepal of $13.14 per pregnancy (based
on program estimates extrapolated from a research study).
The estimated benefit:cost ratio of 6.7:1 is similar to the
median benefit:cost ratio for iron fortification estimated by
Horton and Ross [6] for a range of countries. Supplementation
of women is more costly per person, but has a stronger effect on
anaemia. However, fortification benefits both men and women
while supplementation directly benefits only women and will
only have large labour market benefits in countries where
women’s participation in the labour market is high. The cost per
woman is around four to five times higher than that of
fortification programs. However, in Viet Nam fortification of
cereals is not easily available for rural areas (rice, the main
staple, is more costly to fortify, and less feasible to fortify given
the lack of central processing). There have been experiments
with fortification of fish sauce however this is not yet on a
commercial scale. At present a supplementation program is the
most feasible method for addressing iron and folate deficiencies
in Viet Nam.
The cost of coverage with weekly iron-folic acid is comparable
to program estimates for distribution of other nutritional
supplements such as twice-yearly vitamin A, and zinc. A recent
survey [25] of the cost of micronutrient supplementation programs
(both published and ‘‘grey’’ literature) identified 43 studies, of
which 31 were for vitamin A, and the rest for iron (7), iodine (4)
and zinc (1). Mean cost per beneficiary were calculated as
USD1.95 (vitamin A), USD3.64 (iodine), USD0.52 (zinc – only 1
program), but was not calculated for iron. Mean cost per person-
year of ‘‘useful’’ coverage was estimated as USD8.53 (vitamin A)
and USD0.74 (iodine) but not available for iron or zinc. Although
Vitamin A capsules were less costly than iron per person
(USD0.12/person/year compared to USD0.36), delivery costs
for vitamin A were higher: USD1.83 compared to USD0.40. This
may reflect lower coverage with volunteer health workers and
lower population densities in Africa, where most costing studies of
vitamin A were done.
Table 3. Effectiveness of the Yen Bai iron supplementation
and de-worming program.
Survey Sample size
Haemoglobin
(g/L)
Prevalence of
anaemia
Baseline 349 122 38%
3 month 574 126 27%
12 month 572 131 20%
30 month 303 130 19%
Data sourced from Casey et al [13].
doi:10.1371/journal.pone.0023723.t003
Table 2. Annual cost of weekly iron supplementation, Yen Bai
province, Vietnam.
Project costs (USD)
Iron-folic acid supplements (purchase, transport and storage)
Promotion
Training
Monitoring
62,734
814
4,086
25,330
Subtotal 92,878
Health care system costs (USD)
National Institute
District Health Service
Commune Health Service
Village Health Workers
608
4,496
7,812
28,020
Total 133,900
Number of women targeted
Number of women treated
1
250,000
175,581
Cost per woman treated 0.76
181% of target population accessed; compliance (taking .=75% of
recommended intake) was 87%[13].
doi:10.1371/journal.pone.0023723.t002
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however somewhat similar. Promotion accounted for 11% of the
non-supplement costs, training 6% , volunteer time 24%,
temporary paid workers 10%, permanent, salaried staff 41%,
and other 11% for vitamin A. For the Yen Bai iron-folic acid
supplementation program, promotion accounted for 1% of the
non-supplement costs, training 6%, monitoring 36%, village
health worker time 39%, and permanent, salaried staff 18%.
The costs of providing weekly iron-folic acid in a program
setting may also be useful for estimating costs of providing
micronutrient powders for home fortification for children 6–36
months, and for therapeutic zinc for children under five. Program
cost data for these latter two interventions are almost non-existent.
This study therefore fills a major gap in the cost literature,
namely estimating the cost of implementing weekly iron
supplementation programs. It has policy significance given the
recommendation to expand coverage of supplementation with
weekly iron and folic acid supplements to women of reproductive
age, as well as for other similar supplementation programs, such as
multiple micronutrient powders and zinc for children.
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